当前位置: 首页 > 期刊 > 《中国医药科学》 > 2013年第1期
编号:13174022
蟾毒灵抗肝细胞癌作用及机制研究(4)
http://www.100md.com 2013年1月1日 《中国医药科学》 2013年第1期
     [25] Gao Y,Li HX,Xu LT,et al.Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK[J].Molecular Biology Reports,2012,39(2):1683-1689.

    [26] 刘颖,陈志强,陶蓓蕾,等.蟾毒灵血浆蛋白结合率的测定[J].中国医药杂志,2009,34(21):2817-2820.

    [27] Toma S,Hirai Y,Sugimoto C,et al.Metabolic fate of buaflin in rats[J].Yakugaku Zasshi,1991,111(11):676-686.

    [28] Bick RJ,Poindexter BJ,Sweney RR,et al.Effects of Chan Su,a traditional Chinese medicine,on the calcium transients of isolatedcardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blocking[J].Life Sci,2002,72(6):699-709.

    [29] Liu PF,Zhu MJ,Li YG,et al.The research oncytotoxicity and cellular uptake of mPEG-PLGA-PLL nanoparticles. Proceedings of 2009 international conference on advanced fibers and polymer materials[J].2009,1-2:1190-1192.

    [30] Kostakis C,Byard RW.Sudden death associated with intravenous injection of toad extract[J].Forensic Sci Int,2009,188(1-3):e1-e5.

    (收稿日期:2012-12-06), http://www.100md.com(盖继钦 秦建民 范跃祖)
上一页1 2 3 4